Underweight CL via modest sizing (≤2%); conditional 25-30% trim into $88.50-$90.00 rally zone only
Underweight via sizing (≤2% portfolio, below benchmark) is correct per the four-stack convergence (broken technicals, stretched 20.8x P/E vs. ~5% decelerating organic growth, 320bps SG&A operating deleverage, hostile macro with 97% probability of no 2026 cuts); execute 25-30% trim ONLY into $88.50-$90.00 relief rally zone; do NOT trim at $86.46 structural breakdown; hard stop $84.50 closing-only with volume >5M; re-engagement triggers are mechanical per specified conditions.
| Position | Action |
|---|---|
| Underweight position | ≤2% of portfolio (below benchmark weight for 0.32-beta defensive) |
| Income-only mandate | Trim only 5-7% to reach ~93-95% benchmark weight |
| Re-engagement: pullback to $82-84 with RSI <30 + bullish divergence | Scale into full benchmark weight (asymmetric re-entry) |
| Re-engagement: close >$87.71 (200 SMA) on volume >5M with MACD histogram positive | Add 10-15% toward Hold |
CL is a fortress stock at a healthy technical entry point during a normal pullback, with the bears fighting the wrong battle by focusing on distorted TTM metrics rather than the company's 61% EPS expansion, strategic portfolio transformation, 130-year dividend streak, and defensive rotation tailwind in a higher-for-longer Fed environment.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 86.65 | neutral |
| 50 SMA | 90.00 | bearish |
| 200 SMA | 87.71 | neutral |
| RSI (14) | 41.16 | neutral |
| MACD | -1.16 | bearish |
| MACD Signal | -1.16 | bearish |
| Bollinger Upper | 90.24 | neutral |
| Bollinger Middle | 87.52 | neutral |
| Bollinger Lower | 84.80 | bearish |
| ATR (14) | 1.52 | neutral |
| VWMA (20) | 86.98 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close >$87.71 (200 SMA) on volume >5M with MACD histogram positive
Then: Add 10-15% toward Hold
Forward valuation is fair, not premium — TTM distortion masks strong normalized earnings
EV: +$14.34 to +$12.87 (targets: $90 → $94 → $98 → $99.33 from $86.46 entry) · concedes: Technical chart looks ugly on the surface — price below 10 EMA, 50 SMA, and pressing on 200 SMA with negative MACD; TTM PE of 33.59x appears expensive on headline (though forward PE is 20.81x); North America business is shrinking — though this enables the strategic divestiture; Input cost pressures cited at Barclays conference are a legitimate watch item (oil +14% Brent in September); Stock at 52-week highs ($99.33) makes current levels attractive but requires patience
CL is a defensive name with deteriorating momentum, stretched valuation at the high end of its historical range, decelerating fundamentals (SG&A outpacing revenue by 320bps), a shrinking portfolio via the 1.5%-of-market-cap divestiture, and a macro environment hostile to defensive multiples with 30-year Treasuries at 2002 highs and 97% probability of zero Fed cuts in 2026.
· concedes: CL has a strong brand portfolio and the 130-year dividend streak is a category credential; Gross margin did expand 140bps year-over-year, indicating some pricing power; The divestiture, if executed well, could improve margin profile even if it shrinks revenue; The death cross and lower-high sequence could eventually resolve as a bottom if price reclaims $91.50 with rising volume
→ vs conservative: CL as 'Dividend King' with 130 years of uninterrupted payments is a yield trap - 2.45% vs 4% risk-free Treasury is negative real yield, not safety
→ vs conservative: Waiting for 200 SMA reclaim at $87.71 means missing the meat of the move - by the time trend confirms, you've already lost
→ vs conservative: 'Right company, wrong time, wrong price' leading to HOLD is a contradiction - wrong price and wrong time means reduce exposure
→ vs neutral: $1B+ divestiture is speculative - deal hasn't closed, hasn't priced, management only 'exploring' with Goldman
→ vs neutral: Capital returns labeled 'solid' ignores operating deleverage - 320 bps cost growth exceeding revenue is structural margin erosion
→ vs neutral: 'Potential catalyst' anchoring is not investing - broken technicals and margin compression require action, not hope
Support: 87.71 · 86 · 84.8 · 84.13 · 82.99 · 82.15 | Resistance: 87.52 · 88.65 · 90 · 90.24
CL is trading at $86.46 (2026-09-29 close), a fresh multi-month low, with price below all major moving averages and sitting between the Bollinger middle (87.52) and lower (84.80) bands. The stock shows a clear lower-high, lower-low structure since the July 2026 peak near $94.59, with momentum weak (RSI 41.16, MACD -1.16) but not oversold. The critical support level is the 200 SMA at $87.71; a breakdown below the lower Bollinger band at $84.80 would open downside targets toward $82–$83. Volume confirms distribution on the decline (10.84M shares on 2026-09-18) but lacks panic-selling levels. ATR of $1.52 suggests moderate volatility compressing slightly. Rating: HOLD with defensive bias—no new longs until price reclaims the 20 SMA at $87.52.
Market Capitalization
$68.0 billion
TTM PE Ratio
33.59
Forward PE
20.81
PEG Ratio
1.58
Price to Book
288.24
EPS (TTM)
$2.54
Forward EPS
$4.10
Dividend Yield
2.45%
Beta
0.32
52-Week High
$99.33
52-Week Low
$74.55
50-Day Moving Average
$89.99
200-Day Moving Average
$88.38
Total Assets
$16.79B
Total Equity
$236M
Goodwill & Intangibles
$4.60B
Cash & Equivalents
$1.37B
Total Debt
$7.86B
Net Debt
$6.49B
Current Ratio
1.026
Long-Term Debt
$7.82B
Treasury Stock
$28.93B
Tangible Book Value
-$4.36B
Q2 2026 Revenue
$5,361M
Q2 2026 Gross Profit
$3,296M
Q2 2026 Operating Income
$1,016M
Q2 2026 Net Income
$693M
Q2 2026 Diluted EPS
$0.86
Q4 2025 Net Income
($37M)
Q4 2025 EPS
($0.05)
Gross Margin
60.4%
Operating Margin
20.97%
Net Profit Margin
9.68%
EBITDA
$4.98B
ROE
2.67%
ROA
15.84%
TTM Free Cash Flow
$3.46B
Q2 2026 OCF
$995M
Q2 2026 CapEx
$128M
Q2 2026 Free Cash Flow
$867M
Q2 2026 Dividends
$462M
Q2 2026 Buybacks
$291M
TTM Dividends + Buybacks
~$7.2B
Net Debt/EBITDA
~1.3x
Revenue YoY Growth
+4.9%
Inventory
$2.18B
Working Capital (Q2 2026)
+$160M
Strengths
Concerns
Colgate-Palmolive presents as a high-quality defensive compounder trading near its 52-week high with accelerating revenue growth (+4.9% YoY to $5.36B), expanding gross margins (61.5%), strong FCF generation ($3.46B TTM), and aggressive capital returns ($7.2B TTM), though valuation appears full at a Forward PE of 20.81x and net margins of 9.68% remain below historical norms due to SG&A growing faster than revenue, while the balance sheet carries $6.49B in net debt with a conservative 1.3x Net Debt/EBITDA ratio and exceptional 0.32 beta supporting defensive positioning.
Macro: The macro environment presents a challenging setup for defensive consumer staples: the Fed is expected to hold rates with 97% probability of zero cuts in 2026, the 30-year Treasury hit its highest level since 2002 (7.58% mortgage rates), and Brent crude surged +14% MoM in September due to Middle East tensions (Iran, Strait of Hormuz) threatening energy and freight costs. August PCE inflation is expected to remain sticky, potentially opening the door to an October rate hike. Despite low recession odds (8%), the higher-for-longer rate environment structurally compresses consumer staples valuation multiples and widens equity risk premiums, while oil-driven cost inflation directly pressures CL's input costs.